Gp91 phox contributes to the development of experimental inflammatory bowel disease

Immunology and Cell Biology

Volumn 89, Issue 8, 2011, Pages 853-860

  Bao, Shisan ^a   Carr, Emma D J ^a   Xu, Ying Hua ^a   Hunt, Nicholas H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

colonic inflammation; gp91; IBD; oxidative burst

Indexed keywords

GLYCOPROTEIN GP 91; INTERLEUKIN 6; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTERITIS; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; INTESTINE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; TISSUE INJURY; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; COLON; DEXTRAN SULFATE; ENDOTHELIUM, VASCULAR; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-6; INTESTINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NEUTROPHILS; RESPIRATORY BURST;

MUS;

EID: 80855128740     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.4     Document Type: Article

References (33)

1. Bamias G, Nyce MR, De La Rue SA, Cominelli F. New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med 2005; 143: 895-904. (Pubitemid 46202223)
2. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117: 514-521. (Pubitemid 46348505)
3. Fiocchi C. Probiotics in inflammatory bowel disease: yet another mechanism of action? Gastroenterology 2006; 131: 2009-2012. (Pubitemid 44958535)
4. French N, Pettersson S. Microbe-host interactions in the alimentary tract: the gateway to understanding inflammatory bowel disease. Gut 2000; 47: 162-163. (Pubitemid 30489753)
5. Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol 2010; 38: 3-10.
6. Babior BM. NADPH oxidase: an update. Blood 1999; 93: 1464-1476. (Pubitemid 29102471)
7. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4: 181-189. (Pubitemid 38339084)
8. Curnutte JT, Scott PJ, Babior BM. Functional defect in neutrophil cytosols from two patients with autosomal recessive cytochrome-positive chronic granulomatous disease. J Clin Invest 1989; 83: 1236-1240. (Pubitemid 19113036)
9. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G et al. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001; 194: 1207-1218. (Pubitemid 33055040)
10. Brown DI, Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 2009; 47: 1239-1253.
11. Mori M, Stokes KY, Vowinkel T, Watanabe N, Elrod JW, Harris NR et al. Colonic blood flow responses in experimental colitis: time course and underlying mechanisms. Am J Physiol Gastrointest Liver Physiol 2005; 289: G1024-G1029. (Pubitemid 41740606)
12. Xu Y, Hunt NH, Bao S. The correlation between proinflammatory cytokines, MAdCAM-1 and cellular infiltration in the inflamed colon from TNF-alpha gene knockout mice. Immunol Cell Biol 2007; 85: 633-639. (Pubitemid 350224210)
13. Xu Y, Hunt NH, Bao S. The role of granulocyte macrophage-colony- stimulating factor in acute intestinal inflammation. Cell Res 2008; 18: 1220-1229.
14. Xu Y, Hunt NH, Bao S. The effect of restraint stress on experimental colitis is IFN-gamma independent. J Neuroimmunol 2008; 200: 53-61.
15. Mudter J, Neurath MF. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007; 13: 1016-1023. (Pubitemid 47309974)
16. Hamilton JA. GM-CSF in inflammation and autoimmunity. Trends in Immunol 2002; 23: 403-408. (Pubitemid 34804636)
17. Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16-22.
18. Coelho AL, Hogaboam CM, Kunkel SL. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev 2005; 16: 553-560. (Pubitemid 41505516)
19. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80: 617-653.
20. Yamada T, Grisham MB. Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation. Klin Wochenschr 1991; 69: 988-994.
21. Hausmann M, Obermeier F, Paper DH, Balan K, Dunger N, Menzel K et al. In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis. Clin Exp Immunol 2007; 148: 373-381. (Pubitemid 46587594)
22. Hausmann M, Spottl T, Andus T, Rothe G, Falk W, Scholmerich J et al. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages. Clin Exp Immunol 2001; 125: 48-55. (Pubitemid 32703365)
23. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-1367.
24. Noguchi M, Hiwatashi N, Liu ZX, Toyota T. Increased secretion of granulocyte-macro-phage colony-stimulating factor in mucosal lesions of inflammatory bowel disease. Digestion 2001; 63 (Suppl 1): 32-36. (Pubitemid 32098438)
25. Richter J, Andersson T, Olsson I. Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J of Immunol 1989; 142: 3199-3205. (Pubitemid 19129943)
26. Sainathan SK, Hanna EM, Gong Q, Bishnupuri KS, Luo Q, Colonna M et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflammatory Bowel Dis 2008; 14: 88-99. (Pubitemid 351196873)
27. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8: 533-544. (Pubitemid 351913679)
28. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9: 202-209.
29. Mahler M, Bristol IJ, Sundberg JP, Churchill GA, Birkenmeier EH, Elson CO et al. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics 1999; 55: 147-156. (Pubitemid 29093509)
30. Johansson ME, Gustafsson JK, Sjoberg KE, Petersson J, Holm L, Sjovall H et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 2010; 5: e12238.
31. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-209. (Pubitemid 12171880)
32. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350. (Pubitemid 15201434)
33. Coon C, Beagley KW, Bao S. The role of granulocyte macrophage-colony stimulating factor in gastrointestinal immunity to salmonellosis. Scand J Immunol 2009; 70: 106-115.